Accolade (NASDAQ:ACCD) posted its quarterly earnings data on Wednesday. The company reported ($0.32) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.35) by $0.03, MarketWatch Earnings reports. The business had revenue of $38.44 million for the quarter, compared to analyst estimates of $36.20 million. The business’s revenue for the quarter was up 29.7% on a year-over-year basis.
Shares of ACCD stock opened at $49.67 on Friday. The stock’s 50 day moving average is $50.48. Accolade has a 12-month low of $28.68 and a 12-month high of $65.25.
A number of equities analysts have recently commented on ACCD shares. Stifel Nicolaus assumed coverage on shares of Accolade in a research note on Monday, November 16th. They set a “buy” rating and a $48.00 price objective for the company. Piper Sandler raised their target price on shares of Accolade from $55.00 to $57.00 and gave the company an “overweight” rating in a research note on Friday. SVB Leerink raised their target price on shares of Accolade from $44.00 to $53.00 and gave the company a “market perform” rating in a research note on Friday. Morgan Stanley raised their target price on shares of Accolade from $37.00 to $48.00 and gave the company an “overweight” rating in a research note on Friday, October 16th. Finally, BTIG Research assumed coverage on shares of Accolade in a research note on Wednesday. They issued a “buy” rating and a $55.00 target price for the company. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $50.08.
Accolade Company Profile
Accolade, Inc develops and provides technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and with multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists.
Featured Article: What member countries make up the G-20?
Receive News & Ratings for Accolade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accolade and related companies with MarketBeat.com's FREE daily email newsletter.